Learn more

MEDINNOVA GES MED INNOVATIONEN

Overview
  • Total Patents
    47
About

MEDINNOVA GES MED INNOVATIONEN has a total of 47 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are VON KNEBEL DOEBERITZ MAGNUS, SAHLTECH I GOTEBORG AB and GENERA ISTRAZIVANJA D O O.

Patent filings in countries

World map showing MEDINNOVA GES MED INNOVATIONENs patent filings in countries

Patent filings per year

Chart showing MEDINNOVA GES MED INNOVATIONENs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sedlacek Hans-Harald 17
#2 Sendtner Michael 14
#3 Goebel Werner 9
#4 Rossoll Wilfried 9
#5 Pleschka Stephan 8
#6 Wiese Stefan 8
#7 Gentschev Ivaylo 8
#8 Planz Oliver 7
#9 Rapp Ulf R 6
#10 Sendtner Michael Anton 6

Latest patents

Publication Filing date Title
DE10326187A1 Cells as carriers for bacteria
DE10326189A1 Bacterial carriers for nucleotide sequences encoding drugs
DE10313636A1 Use of active substances for the prevention or treatment of viral diseases as well as test system for finding such active substances
DE10313098A1 Test system for finding active substances against prion-induced diseases and active substances for the prevention and treatment of this disease
DE10312846A1 Test system for the detection of substances to promote neurite growth
DE10300222A1 Use of active substances for the prophylaxis and / or therapy of viral diseases
DE10261223A1 Increasing the immune response through substances that influence the function of natural killer cells
DE10239961A1 Test system for finding active substances in diseases of nerve cells
DE10232723A1 Test system for the detection of inhibitors of inositol phosphate kinases and uses of these inhibitors for the prophylaxis or therapy of proliferative diseases
DE10228187A1 Test system for the detection of cancer
DE10208653A1 Microorganism as a carrier of nucleotide sequences coding for cell antigens for the treatment of tumors
DE10208175A1 Nucleotide sequence coding for a TolC and a defined amino acid sequence
DE10206325A1 Coated microorganism
DE10164556A1 Test system for the search or testing of active substances that influence the growth and / or survival of nerve cells
DE10154924A1 Biodegradable copolymers
DE10153335A1 Method for finding pharmacologically active substances that affect the function of nerve cells
DE10147088A1 Use of active substances for the prophylaxis and / or therapy of diseases which are associated with cell growth disorders and test system for finding such active substances
DE10138912A1 Use of active substances for the prophylaxis and / or therapy of viral diseases as well as test system for finding such active substances
DE10113513A1 Drug combination of kinase inhibitor and neurotropic factor, useful for treating and/or preventing nerve and/or glial cell damage, e.g. associated with neurodegenerative diseases
DE10102722A1 Method and test system for finding nerve cell protective substances